HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles

Rheumatology (United Kingdom)

Volumn 52, Issue 11, 2013, Pages 1973-1982

  Nordang, Gry B N ^a   Flåm, Siri T ^a   Maehlen, Marthe T ^a,b   Kvien, Tore K ^b   Viken, Marthe K ^a,c   Lie, Benedicte A ^a,c  

^a UNIVERSITY OF OSLO   (Norway)

^b DIAKONHJEMMET HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Genetic risk; Hla C.; Hla DRB1; Mhc; Ra

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; EPITOPE; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DPB1 ANTIGEN; HLA DRB1 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA A ALLELE; HLA B ALLELE; HLA C ALLELE; HLA DPB1 ALLELE; HLA DRB1 ALLELE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SHARED EPITOPE ALLELE; SINGLE NUCLEOTIDE POLYMORPHISM;

GENETIC RISK; HLA-C; HLA-DRB1; MHC; RA;

ALLELES; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISTOCOMPATIBILITY TESTING; HLA-C ANTIGENS; HLA-DRB1 CHAINS; HUMANS; PEPTIDES, CYCLIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84886292691     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/ket252     Document Type: Article

References (42)

1. Syversen SW, Gaarder PI, Goll GL et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008;67:212-7.
2. Stahl EA, Raychaudhuri S, Remmers EF, et al. Genomewide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet 2010;42: 508-14.
3. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978;298:869-71.
4. Jajic Z, Jajic I. Antigens of HLA-DR locus in rheumatoid arthritis. Br J Rheumatol 1988;27(Suppl 2):139-40.
5. Wordsworth P, Pile KD, Buckely JD, et al. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992;51:585-91.
6. Gregersen PK, Shen M, Song QL, et al. Molecular diversity of HLA-DR4 haplotypes. Proc Natl Acad Sci USA 1986;83: 2642-6.
7. Gregersen PK, Moriuchi T, Karr RW, et al. Polymorphism of HLA-DR beta chains in DR4, -7, and -9 haplotypes: implications for the mechanisms of allelic variation. Proc Natl Acad Sci USA 1986;83:9149-53.
8. Hall FC, Weeks DE, Camilleri JP, et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. QJM 1996;89:821-9.
9. Milicic A, Lee D, Brown MA, Darke C, et al. HLA-DR/DQ haplotype in rheumatoid arthritis: novel allelic associations in UK Caucasians. J Rheumatol 2002;29:1821-6.
10. du Montcel ST, Michou L, Petit-Teixeira E, et al. New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility. Arthritis Rheum 2005;52:1063-8.
11. Verpoort KN, van Gaalen FA, van der Helm-van Mil AH, et al. Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis. Arthritis Rheum 2005;52:3058-62.
12. Irigoyen P, Lee AT, Wener MH, et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005;52: 3813-8.
13. Lundstrom E, Kallberg H, Smolnikova M, et al. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibodypositive and anti-citrullinated protein antibodynegative rheumatoid arthritis. Arthritis Rheum 2009;60: 924-30.
14. van der Woude D, Lie BA, Lundstrom E, et al. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations. Arthritis Rheum 2010;62:1236-45.
15. Mulcahy B, Waldron-Lynch F, McDermott MF, et al. Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritis. Am J Hum Genet 1996;59:676-83.
16. Ota M, Katsuyama Y, Kimura A, et al. A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region. Genomics 2001;71: 263-70.
17. Jawaheer D, Li W, Graham RR, et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002; 71:585-94.
18. Newton JL, Harney SM, Timms AE, et al. Dissection of class III major histocompatibility complex haplotypes associated with rheumatoid arthritis. Arthritis Rheum 2004;50:2122-9.
19. Newton JL, Harney SM, Wordsworth BP, et al. A review of the MHC genetics of rheumatoid arthritis. Genes Immun 2004;5:151-7.
20. Lee HS, Lee AT, Criswell LA, et al. Several regions in the major histocompatibility complex confer risk for anti-CCPantibody positive rheumatoid arthritis, independent of the DRB1 locus. Mol Med 2008;14:293-300.
21. Ding B, Padyukov L, Lundstrom E, et al. Different patterns of associations with anti-citrullinated protein antibodypositive and anti-citrullinated protein antibody-negative rheumatoid arthritis in the extended major histocompatibility complex region. Arthritis Rheum 2009;60:30-8.
22. Vignal CM, Bansal AT, Balding DJ. Using penalised logistic regression to fine map HLA variants for rheumatoid arthritis. Ann Hum Genet 2011;75:655-64.
23. Orozco G, Barton A, Eyre S, et al. HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort. Genes Immun 2011;12: 169-75.
24. Raychaudhuri S, Sandor C, Stahl EA, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012;75:655-64.
25. Vignal C, Bansal AT, Balding DJ, et al. Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci. Arthritis Rheum 2009;60:53-62.
26. Yeo TW, De Jager PL, Gregory SG, et al. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Ann Neurol 2007;61:228-36.
27. Nejentsev S, Howson JM, Walker NM, et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007;450:887-92.
28. de Bakker PI, McVean G, Sabeti PC, et al. A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC. Nat Genet 2006;38:1166-72.
29. Malkki M, Single R, Carrington M, et al. MHC microsatellite diversity and linkage disequilibrium among common HLAA, HLA-B, DRB1 haplotypes: implications for unrelated donor hematopoietic transplantation and disease association studies. Tissue Antigens 2005;66:114-24.
30. Leslie S, Donnelly P, McVean G. A statistical method for predicting classical HLA alleles from SNP data. Am J Hum Genet 2008;82:48-56.
31. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
32. Sayer DC, Whidborne R, De SD, et al. A multicenter international evaluation of single-tube amplification protocols for sequencing-based typing of HLA-DRB1 and HLADRB3,4,5. Tissue Antigens 2004;63:412-23.
33. Viken MK, Blomhoff A, Olsson M, et al. Reproducible association with type 1 diabetes in the extended class I region of the major histocompatibility complex. Genes Immun 2009;10:323-33.
34. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 2005;5: 201-14.
35. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007;81:559-75.
36. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum Hered 2008;66:87-98.
37. Valdes AM, Thomson G. Detecting disease-predisposing variants: the haplotype method. Am J Hum Genet 1997; 60:703-16.
38. Ahmad T, Neville M, Marshall SE, et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet 2003;12: 647-56.
39. Blomhoff A, Olsson M, Johansson S, et al. Linkage disequilibrium and haplotype blocks in the MHC vary in an HLA haplotype specific manner assessed mainly by DRB1*03 and DRB1*04 haplotypes. Genes Immun 2006;7: 130-40.
40. Klareskog L, Stolt P, Lundberg K, et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLADR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54:38-46.
41. Alzabin S, Williams RO. Effector T cells in rheumatoid arthritis: lessons from animal models. FEBS Lett 2011;585: 3649-59.
42. Jenisch S, Henseler T, Nair RP, et al. Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet 1998;63:191-9.